Advanced Therapies Week 2022 | The importance of collaboration in cell and gene therapy development

Delara Motlagh, PhD, MS, EMBA, Terumo Blood and Cell Technologies, Lakewood, CO, provides an overview on the significance of reinforcing collaboration and harmonization across different stakeholders involved in the development of advanced therapies. Due to the complexity and novelty of cell and gene therapies, multiple stakeholders are required throughout the development process from logistics to regulatory approval. Dr Motlagh additionally highlights existing collaborative efforts between academia and industry, where academic institutions can foster innovation and pharmaceuticals enable the commercialization of products. This interview took place at Advanced Therapies Week 2022.